- Home
- NOM vs TENX Comparison
NOM vs TENX Comparison
Compare NOM & TENX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NOM
- TENX
- Stock Information
- Founded
- NOM 1993
- TENX 1967
- Country
- NOM United States
- TENX United States
- Employees
- NOM N/A
- TENX N/A
- Industry
- NOM Investment Managers
- TENX Biotechnology: Pharmaceutical Preparations
- Sector
- NOM Finance
- TENX Health Care
- Exchange
- NOM Nasdaq
- TENX Nasdaq
- Market Cap
- NOM 25.8M
- TENX 27.3M
- IPO Year
- NOM N/A
- TENX N/A
- Fundamental
- Price
- NOM $11.22
- TENX $6.13
- Analyst Decision
- NOM
- TENX Strong Buy
- Analyst Count
- NOM 0
- TENX 4
- Target Price
- NOM N/A
- TENX $16.67
- AVG Volume (30 Days)
- NOM 6.9K
- TENX 34.2K
- Earning Date
- NOM 01-01-0001
- TENX 11-12-2025
- Dividend Yield
- NOM 3.39%
- TENX N/A
- EPS Growth
- NOM N/A
- TENX N/A
- EPS
- NOM N/A
- TENX N/A
- Revenue
- NOM N/A
- TENX N/A
- Revenue This Year
- NOM N/A
- TENX N/A
- Revenue Next Year
- NOM N/A
- TENX N/A
- P/E Ratio
- NOM N/A
- TENX N/A
- Revenue Growth
- NOM N/A
- TENX N/A
- 52 Week Low
- NOM $8.52
- TENX $3.25
- 52 Week High
- NOM $10.48
- TENX $7.89
- Technical
- Relative Strength Index (RSI)
- NOM 60.17
- TENX 59.63
- Support Level
- NOM $10.84
- TENX $6.02
- Resistance Level
- NOM $11.26
- TENX $6.25
- Average True Range (ATR)
- NOM 0.19
- TENX 0.12
- MACD
- NOM 0.03
- TENX 0.02
- Stochastic Oscillator
- NOM 84.99
- TENX 66.67
About NOM Nuveen Missouri Quality Municipal Income Fund
Nuveen Missouri Quality Municipal Income Fund is a diversified, closed-end management investment company operating in the United States. The Fund's investment objective is current income exempt from both regular federal income taxes and Missouri personal income taxes, and to enhance portfolio value relative to the Missouri municipal bond market by investing in tax-exempt Missouri municipal obligations that are underrated or undervalued or that represent municipal market sectors that are undervalued. The fund invests in municipal securities as well as floating rate securities, and derivatives such as futures, options, and swap contracts to the necessary extent.
About TENX Tenax Therapeutics Inc.
Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.